March 23, 2018 / 3:58 PM / 9 months ago

Abbott's Alere resolves U.S. diagnostic device probe for $33.2 mln

BOSTON, March 23 (Reuters) - Alere Inc has agreed to pay $33.2 million to resolve claims it knowingly sold unreliable diagnostic testing devices to hospitals prior to its acquisition by Abbott Laboratories last year, the U.S. Justice Department said on Friday.

The Justice Department said that Massachusetts-based Alere, from 2006 to 2012, sold its Triage-branded devices to hospitals that government healthcare programs paid for, despite receiving customer complaints about the erroneous results they produced. (Reporting by Nate Raymond in Boston; Editing by Bernadette Baum)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below